Arlington, MA, United States of America

Issac E Marx

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Amgen Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Issac E Marx. Retrieved from https://idiyas.com/inventor/issac-e-marx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Issac E Marx: Innovator in Bicyclic Ketone Sulfonamide Compounds

Introduction

Issac E Marx is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target voltage-gated sodium channels.

Latest Patents

Issac E Marx holds a patent for bicyclic ketone sulfonamide compounds. This invention provides compounds of Formula (I), which include enantiomers, diastereomers, and atropisomers, or mixtures thereof, as well as pharmaceutically acceptable salts. These compounds serve as inhibitors of voltage-gated sodium channels, specifically Nav 1.7. They are particularly useful in treating diseases that can be managed through sodium channel inhibition, such as pain disorders, cough, or itch. Additionally, pharmaceutical compositions containing these compounds are also provided in the patent.

Career Highlights

Issac E Marx is associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Matthew M Weiss and Benjamin Charles Milgram. Their collaboration has contributed to the advancement of research and development in their field.

Conclusion

Issac E Marx is a distinguished inventor whose work on bicyclic ketone sulfonamide compounds has the potential to impact the treatment of various medical conditions. His contributions to Amgen Inc. and the pharmaceutical industry highlight his commitment to innovation and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…